B. EVIDENCE RELIED UPON BY SILK
7 The application was supported by the following affidavits:
(a) an affidavit of Ms Crosby, a solicitor employed by Kain Lawyers, the solicitors acting for SILK in the Scheme, sworn on 7 September 2023, which annexed a company search of SILK and an ASX announcement of the Scheme, which included a copy of the SID;
(b) an affidavit of Alyce Ricciardi, a solicitor employed by Kain Lawyers, sworn on 28 September 2023, which addressed the verification process undertaken for SILK and her role in coordinating that process;
(c) an affidavit of Andrew Glynn Cosh, a non-executive director of SILK and proposed alternative Chair of the Scheme Meeting, affirmed on 28 September 2023, which addressed disclosure under r 3.2 of the Rules;
(d) an affidavit of Ms Crosby, sworn on 29 September 2023, which addressed the provision of documents to ASIC, evidence relating to the independent expert's report, the eligibility of SILK Shareholders with share scheme loans to vote at the Scheme Meeting and that the Scheme Consideration to be received by those shareholders would exceed the relevant loans, a matter relating to current litigation, a side deed entered into by SILK and API on 28 September 2023 to substitute the forms of the Scheme and deed poll previously agreed and which annexed both the email and letter to be sent to SILK Shareholders under the proposed orders, the side deed, the proposed scripts for shareholder communications and management sign-offs in relation to the due diligence program outline;
(e) an affidavit of Boris Paul Bosnich, the Chairman and a non-executive director of SILK, affirmed on 28 September 2023, which, among other matters, addressed SILK's business and capital structure, the Scheme, the Scheme Consideration, the Special Dividend, the Scheme Booklet, conditions precedent, the exclusivity and break fees provisions, the proposed treatment of performance rights, share scheme loans, incentive payments to certain employees, special exertion fees to be paid to the non-executive directors and the company secretary, SILK's board recommendation, the foreign resident capital gains tax withholding regime, the independent expert, despatch of the scheme materials, the Scheme Meeting, verification of the Scheme Booklet, shareholder communications, advertising for the second court hearing and disclosure under r 3.2 of the Rules; and
(f) an affidavit of Emily Jane Amos, Managing Director of Wesfarmers Health, a division of Wesfarmers and a director of API, sworn on 3 October 2023, which addressed the verification of the "API Information" in the Scheme Booklet, the execution of the deed poll and the receipt by API from Wesfarmers of an unconditional and irrevocable undertaking regarding funding of the Scheme Consideration;
(g) an affidavit of Ms Crosby, sworn on 3 October 2023, which annexed an updated proxy form and a revised version of the proposed letter to be sent to SILK Shareholders;
(h) an affidavit of Ms Crosby, sworn on 4 October 2023, which annexed marked up pages showing changes to the Scheme Booklet since the version attached to Mr Bosnich's affidavit, a clean copy of the Scheme Booklet (together with annexures, including a copy of the Scheme), a letter from ASIC dated 3 October 2023 confirming it did not intend to intervene to oppose the Scheme and the proposed ASX announcement regarding the second court hearing.